INVO Fertility (IVF) Income towards Parent Company (2011 - 2025)
INVO Fertility (IVF) reported Income towards Parent Company of -$541247.0 for Q2 2025, up 75.89% year-over-year from -$307714.1 in Q2 2024, and up 96.89% on a QoQ basis from -$17.4 million in Q1 2025.
INVO Fertility (IVF) has 15 years of Income towards Parent Company data on file, last reported at -$541247.0 in Q2 2025.
- Quarterly Income towards Parent Company rose 75.89% year-over-year to -$541247.0 in Q2 2025, while the trailing twelve-month figure through Sep 2025 was -$21.6 million (down 188.81% YoY) and the FY2024 annual result came in at -$9.1 million, down 13.2% from the prior year.
- Income towards Parent Company improved to -$541247.0 in Q2 2025 per IVF's latest filing, from -$17.4 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $101782.0 in Q4 2021 and bottomed at -$17.4 million in Q1 2025.
- The 5-year median for Income towards Parent Company is -$2.3 million (2021), against an average of -$2.9 million.
- The widest annual swing landed in 2021, when Income towards Parent Company jumped 102.67%; it then plunged 2818.59% in 2022.
- Tracing IVF's Income towards Parent Company over 5 years: stood at $101782.0 in 2021, then sank by 2818.59% to -$2.8 million in 2022, then advanced by 27.88% to -$2.0 million in 2023, then plunged by 81.57% to -$3.6 million in 2024, then surged by 85.06% to -$541247.0 in 2025.
- Per Business Quant, the three latest IVF Income towards Parent Company figures stand at -$541247.0 (Q2 2025), -$17.4 million (Q1 2025), and -$3.6 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -541,247.00 |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Sep 30, 2023 | -1.25 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -2.80 Mn |
| Mar 31, 2022 | -2.70 Mn |
| Dec 31, 2021 | 101,782.00 |
| Sep 30, 2021 | -2.48 Mn |
| Jun 30, 2021 | -1.82 Mn |
| Mar 31, 2021 | -2.45 Mn |
| Dec 31, 2020 | -3.81 Mn |
| Sep 30, 2020 | -1.77 Mn |
| Jun 30, 2020 | -1.32 Mn |
| Mar 31, 2020 | -1.44 Mn |
| Dec 31, 2019 | -757,088.00 |
| Sep 30, 2019 | -710,334.00 |
| Jun 30, 2019 | -241,552.00 |
| Mar 31, 2019 | -458,570.00 |
| Dec 31, 2018 | -771,380.00 |
| Sep 30, 2018 | -294,860.00 |
| Jun 30, 2018 | -1.87 Mn |
| Mar 31, 2018 | -144,723.00 |
| Dec 31, 2017 | -201,468.00 |
| Sep 30, 2017 | -148,848.00 |
| Jun 30, 2017 | -136,974.00 |
| Mar 31, 2017 | -214,873.00 |
| Dec 31, 2016 | -276,409.00 |
| Sep 30, 2016 | -210,822.00 |
| Jun 30, 2016 | -1.46 Mn |
| Mar 31, 2016 | -181,312.00 |
| Dec 31, 2015 | -244,126.00 |
| Sep 30, 2015 | -123,195.00 |
| Jun 30, 2015 | -4.45 Mn |
| Mar 31, 2015 | -144,658.00 |
| Dec 31, 2014 | -1.31 Mn |
| Sep 30, 2014 | -117,719.00 |
| Jun 30, 2014 | -186,773.00 |
| Mar 31, 2014 | -117,319.00 |
| Dec 31, 2013 | -139,150.00 |
| Sep 30, 2013 | -213,965.00 |
| Jun 30, 2013 | -104,885.00 |
| Mar 31, 2013 | -302,679.00 |
| Dec 31, 2012 | -43,065.00 |
| Sep 30, 2012 | -240,349.00 |
| Jun 30, 2012 | -139,301.00 |
| Mar 31, 2012 | -243,739.00 |
| Dec 31, 2011 | -192,532.00 |
| Sep 30, 2011 | -99,196.00 |
| Jun 30, 2011 | -306,917.00 |